throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`_________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_________________________________
`
`
`
`NOVEN PHARMACEUTICALS, INC.
`AND MYLAN PHARMACEUTICALS INC.,
`Petitioners
`
`v.
`
`NOVARTIS AG AND LTS LOHMANN THERAPIE-SYSTEME AG,
`Patent Owners
`
`_________________________________
`
`
`
`Inter Partes Review No.: 2014-005491
`
`U.S. Patent 6,316,023
`
`PETITIONER’S REQUEST FOR
`ORAL ARGUMENT UNDER 37 C.F.R. § 42.70
`
`
`
`
`
`
`
`
`1
`
`
`
`Case IPR2015-00265 has been joined with this proceeding.
`
`1
`
`
`
`

`
`PETITIONER’S REQUEST FOR
`ORAL ARGUMENT UNDER 37 C.F.R. § 42.70
`
`Pursuant to the Board’s Scheduling Order dated October 14, 2014 (Paper
`
`11), Petitioner Noven Pharmaceuticals, Inc. (“Noven”) respectfully requests oral
`
`argument, currently scheduled for June 2, 2015. Noven also requests that the
`
`hearing in this matter be joined with the hearing in IPR 2014-00550 due to the
`
`overlapping issues in the two IPRs.
`
`Pursuant to 37 C.F.R. § 42.70(a), Noven intends to argue the following
`
`issues:
`
`1. Any issues addressed by Petitioner, including in the Petitions for Inter
`
`Partes Review and Replies, in the ’550 and ’549 proceedings. In
`
`particular, as to the patentability of claims 1, 2, 4, 5, 7, and 8 in the ’023
`
`patent2, whether a person of ordinary skill in the art as of January 1998
`
`would have maintained a reasonable expectation that the drug
`
`rivastigmine was susceptible to oxidative degradation, and therefore,
`
`whether the combination of rivastigmine with an antioxidant in a
`
`pharmaceutical formulation (and especially a transdermal delivery
`
`system) was a patentable invention.
`
`
`2
`
`As to the ’031 patent, the subject of IPR2014-00550, the questions posed
`
`would be with respect to claims 1-3, 7, 15, 16, and 18.
`
`
`
`2
`
`
`
`

`
`2. Any issues properly raised by Patent Owners, including in Patent
`
`Owners’ Responses, in the ’550 and ’549 proceedings.
`
`3. Rebuttal to issues raised by Patent Owners.
`
`4. Noven’s motion(s) to exclude evidence.
`
`5. Any motion to exclude evidence by Patent Owners.
`
`Because of the number of matters disputed, Noven requests 60 minutes per
`
`side of oral argument in the joined hearings for IPR2014-00550 and IPR2014-
`
`00549. Noven also requests the ability to use audio/visual equipment to display
`
`demonstrative exhibits, including the use of a projector and screen for a
`
`PowerPoint presentation.
`
`Respectfully submitted,
`
`/Michael K. Levy/
`Steven J. Lee (Reg. No. 31,272)
`Michael K. Levy (Reg. No. 40,699)
`KENYON & KENYON LLP
`One Broadway
`New York, NY 10004-1007
`Tel: 212-425-7200
`Fax: 212-425-5288
`
`Counsel for Petitioner Noven Pharmaceuticals,
`Inc.
`
`
`
`3
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Dated: April 28, 2015
`
`
`
`
`
`

`
`CERTIFICATE OF SERVICE
`
` I
`
` certify pursuant to 37 C.F.R. §42.6(e) that a copy the foregoing Petitioner’s
`
`Request for Oral Argument was served electronically on April 28, 2015 to counsel
`
`for Patent Owners at the following email address: ExelonPatchIPR@fchs.com.
`
`/Christopher J. Coulson/
`Christopher J. Coulson (Reg. No. 61,771)
`KENYON & KENYON LLP
`One Broadway
`New York, NY 10004-1007
`Tel: 212-425-7200
`Fax: 212-425-5288
`Counsel for Petitioner Noven Pharmaceuticals,
`Inc.
`
`1
`
`
`
`
`
`Dated: April 28, 2015

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket